Sutro Biopharma, Inc.

Direct answer

Sutro Biopharma, Inc. is publicly traded on NASDAQ under the ticker STRO.

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free protein synthesis...

Can you invest in Sutro Biopharma, Inc.?

Yes. Sutro Biopharma, Inc. is publicly traded on NASDAQ under the ticker STRO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Sutro Biopharma, Inc.

Detailed equity research is provided by MarketSnap.